Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lovejoy

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of the American Academy of Nurse Practitioners|April 5, 2002
Diagnosis and management of chronic prostatitis by primary care providersB Lovejoy
Current Medicinal Chemistry|April 8, 2003
Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelatorsD B Lovejoy, D R Richardson
Frontiers in Aging Neuroscience|August 8, 2014
The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisDavid B Lovejoy, Gilles J Guillemin
Blood|July 2, 2002
Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cellsDavid B Lovejoy, Des R Richardson
Expert Opinion on Investigational Drugs|November 4, 2000
Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasiaD R Richardson, D B Lovejoy
Journal of Molecular Biology|December 5, 1993
Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF)B Lovejoy, D Cascio, D Eisenberg
Neural Regeneration Research|October 17, 2018
Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?Kelly R Jacobs, David B Lovejoy
Blood|May 20, 2004
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessmentJun Yuan, David B Lovejoy, Des R Richardson
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1989
Differences between a supervised and independent strength and conditioning program with chronic low back syndromesK Reilly, B Lovejoy, R Williams, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 9, 2018
Development of a Rapid Fluorescence-Based High-Throughput Screening Assay to Identify Novel Kynurenine 3-Monooxygenase Inhibitor ScaffoldsK R Jacobs, G J Guillemin, D B Lovejoy
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of the American Academy of Nurse Practitioners|April 5, 2002
Diagnosis and management of chronic prostatitis by primary care providersB Lovejoy
Current Medicinal Chemistry|April 8, 2003
Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelatorsD B Lovejoy, D R Richardson
Frontiers in Aging Neuroscience|August 8, 2014
The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisDavid B Lovejoy, Gilles J Guillemin
Blood|July 2, 2002
Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cellsDavid B Lovejoy, Des R Richardson
Expert Opinion on Investigational Drugs|November 4, 2000
Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasiaD R Richardson, D B Lovejoy
Journal of Molecular Biology|December 5, 1993
Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF)B Lovejoy, D Cascio, D Eisenberg
Neural Regeneration Research|October 17, 2018
Inhibiting the kynurenine pathway in spinal cord injury: Multiple therapeutic potentials?Kelly R Jacobs, David B Lovejoy
Blood|May 20, 2004
Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessmentJun Yuan, David B Lovejoy, Des R Richardson
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|June 1, 1989
Differences between a supervised and independent strength and conditioning program with chronic low back syndromesK Reilly, B Lovejoy, R Williams, et al.
SLAS Discovery : Advancing Life Sciences R & D|February 9, 2018
Development of a Rapid Fluorescence-Based High-Throughput Screening Assay to Identify Novel Kynurenine 3-Monooxygenase Inhibitor ScaffoldsK R Jacobs, G J Guillemin, D B Lovejoy
Pageof 8